0929 ET - Abbott's acquisition of Exact Sciences could help revitalize Abbott's diagnostics business, TD Cowen analyst Joshua Jennings said in a report issued shortly before the deal was formerly announced earlier today. Jennings believes integrating Exact would add roughly 2.5 percentage points of incremental organic growth to Abbott's diagnostics segment during the early post-deal period, "essentially restoring the franchise to its historical baseline before pandemic distortions emerged." The acquisition would also likely provide a roughly 50 basis point boost to the entire company's organic revenue growth, a meaningful acceleration for a company of Abbott's scale. (nicholas.miller@wsj.com)

(END) Dow Jones Newswires

November 20, 2025 09:30 ET (14:30 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.